Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06877611
PHASE1
A Phase 1 Study of S-4321
Sponsor: Seismic Therapeutic AU Pty Ltd
View on ClinicalTrials.gov
Summary
This is the first-in-human study of S-4321 designed to provide safety, tolerability, pharmacokinetic, and pharmacodynamic data in healthy volunteers.
Official title: A Phase 1, Randomized, Placebo-Controlled, Double-Blind, Single and Multiple Ascending Dose Trial of S-4321 in Healthy Volunteers
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
96
Start Date
2025-04-03
Completion Date
2026-04
Last Updated
2025-04-15
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
S-4321
S-4321 via subcutaneous or intravenous administration
OTHER
Placebo
Placebo via subcutaneous or intravenous administration.
Locations (1)
Veritus Research
Bayswater, Victoria, Australia